TKNO
|
$2.01
-4.74%
-4.98%
13K
|
Professional, Scientific, and T...
(0.0% 1d)
(-24.9% 1m)
(-0.5% 1y)
(0.0% 2d)
(-18.8% 3d)
(-12.4% 7d)
(952.9%
volume)
Earnings Calendar: 2024-03-11
Market Cap: $ 82,055,008
https://www.teknova.com
Sec
Filling
|
Patents
| 193 employees
Teknova is expediting clinical breakthroughs in the life sciences by providing custom products and reagents for bioprocessing, bioproduction, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova's proprietary processes enable the manufacture and delivery of high quality, custom, made-to-order products on short turnaround times and at scale across all stages of development, including commercialization.
diagnostics
gene therapies
t-cell
add to watch list
Paper trade
email alert is off